This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 100/3/408    most recent 01.RES.0000258116.60404.adv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vahebi, S. Articles by Solaro, R. J. Search for Related Content PubMed PubMed Citation Articles by Vahebi, S. Articles by Solaro, R. J. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Nucleotide Protein UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB CALCIUM COMPOUNDS CALCIUM, ELEMENTAL Related Collections Contractile function Biochemistry and metabolism Cell signalling/signal transduction Heart failure - basic studies

(Circulation Research. 2007;100:408.)
© 2007 American Heart Association, Inc.

Cellular Biology

p38-MAPK Induced Dephosphorylation of -Tropomyosin Is Associated With Depression of Myocardial Sarcomeric Tension and ATPase Activity

Susan Vahebi^*, Asuka Ota^*, Manxiang Li, Chad M. Warren, Pieter P. de Tombe, Yibin Wang, R. John Solaro

From the Department of Physiology and Biophysics (S.V., C.M.W., P.P.d.T., R.J.S.), Center for Cardiovascular Research, College of Medicine, University of Illinois at Chicago; Departments of Anesthesiology and Medicine (A.O., M.L., Y.W.), David Geffen School of Medicine, University of California at Los Angeles.

Correspondence to R. John Solaro, PhD, Department of Physiology and Biophysics, (M/C 901), College of Medicine, University of Illinois at Chicago, 835 S. Wolcott Ave., Chicago, IL 60612-7342. E-mail solarorj{at}uic.edu

Our objective in work presented here was to understand the mechanisms by which activated p38 MAPK depresses myocardial contractility. To test the hypothesis that activation of p38 MAPK directly influences sarcomeric function, we used transgenic mouse models with hearts in which p38 MAPK was constitutively turned on by an upstream activator (MKK6bE). These hearts demonstrated a significant depression in ejection fraction after induction of the transgene. We also studied hearts of mice expressing a dominant negative p38 MAPK. Simultaneous determination of tension and ATPase activity of detergent-skinned fiber bundles from left ventricular papillary muscle demonstrated a significant inhibition of both maximum tension and ATPase activity in the transgenic-MKK6bE hearts. Fibers from hearts expressing dominant negative p38 MAPK demonstrated no significant change in tension or ATPase activity. There were no significant changes in phosphorylation level of troponin-T3 and troponin-T4, or myosin light chain 2. However, compared with controls, there was a significant depression in levels of phosphorylation of -tropomyosin and troponin I in fiber bundles from transgenic-MKK6bE hearts, but not from dominant negative p38 MAPK hearts. Our experiments also showed that p38 MAPK colocalizes with -actinin at the Z-disc and complexes with protein phosphatases (PP2, PP2ß). These data are the first to indicate that chronic activation of p38 MAPK directly depresses sarcomeric function in association with decreased phosphorylation of -tropomyosin.

Key Words: heart failure • myofilaments • protein phosphatase • tropomyosin kinase

This article has been cited by other articles:

				C. Yuan, Q. Sheng, H. Tang, Y. Li, R. Zeng, and R. J. Solaro Quantitative comparison of sarcomeric phosphoproteomes of neonatal and adult rat hearts Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H647 - H656. [Abstract] [Full Text] [PDF]

				S. Jacquet, Y. Nishino, S. Kumphune, P. Sicard, J. E. Clark, K. S. Kobayashi, R. A. Flavell, J. Eickhoff, M. Cotten, and M. S. Marber The Role of RIP2 in p38 MAPK Activation in the Stressed Heart J. Biol. Chem., May 2, 2008; 283(18): 11964 - 11971. [Abstract] [Full Text] [PDF]

				E. Murphy and C. Steenbergen Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury Physiol Rev, April 1, 2008; 88(2): 581 - 609. [Abstract] [Full Text] [PDF]

				N. Hamdani, V. Kooij, S. van Dijk, D. Merkus, W. J. Paulus, C. d. Remedios, D. J. Duncker, G. J.M. Stienen, and J. van der Velden Sarcomeric dysfunction in heart failure Cardiovasc Res, March 1, 2008; 77(4): 649 - 658. [Abstract] [Full Text] [PDF]

				S. C. Wu and R. J. Solaro Protein Kinase C {zeta}: A NOVEL REGULATOR OF BOTH PHOSPHORYLATION AND DE-PHOSPHORYLATION OF CARDIAC SARCOMERIC PROTEINS J. Biol. Chem., October 19, 2007; 282(42): 30691 - 30698. [Abstract] [Full Text] [PDF]

				Y. Wang Mitogen-Activated Protein Kinases in Heart Development and Diseases Circulation, September 18, 2007; 116(12): 1413 - 1423. [Abstract] [Full Text] [PDF]

				J. Mei, C. Wood, M. R. L'Abbe, G. S. Gilani, G. M. Cooke, I. H. Curran, and C. W. Xiao Consumption of Soy Protein Isolate Modulates the Phosphorylation Status of Hepatic ATPase/ATP Synthase {beta} Protein and Increases ATPase Activity in Rats J. Nutr., September 1, 2007; 137(9): 2029 - 2035. [Abstract] [Full Text] [PDF]

				K. A. Sheehan, Y. Ke, and R. J. Solaro p21-Activated kinase-1 and its role in integrated regulation of cardiac contractility Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R963 - R973. [Abstract] [Full Text] [PDF]